ID: ALA404632

Max Phase: Preclinical

Molecular Formula: C49H68O12

Molecular Weight: 849.07

Molecule Type: Small molecule

Associated Items:

Representations

Synonyms (1): Hydrocortisone 21-Hemipimelate
Synonyms from Alternative Forms(1):

    Canonical SMILES:  C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)COC(=O)CCCCCC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C

    Standard InChI:  InChI=1S/C49H68O12/c1-44-18-14-30(50)22-28(44)10-12-32-34-16-20-48(58,46(34,3)24-36(52)42(32)44)38(54)26-60-40(56)8-6-5-7-9-41(57)61-27-39(55)49(59)21-17-35-33-13-11-29-23-31(51)15-19-45(29,2)43(33)37(53)25-47(35,49)4/h22-23,32-37,42-43,52-53,58-59H,5-21,24-27H2,1-4H3/t32-,33-,34-,35-,36-,37-,42+,43+,44-,45-,46-,47-,48-,49-/m0/s1

    Standard InChI Key:  HNXBFWOGLZGAQJ-DBFRINACSA-N

    Associated Targets(Human)

    Skin 286 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Molecule Features

    Natural Product: NoOral: NoChemical Probe: NoParenteral: No
    Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
    Chirality: NoAvailability: NoProdrug: No

    Drug Indications

    MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

    Mechanisms of Action

    Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

    Properties

    Molecular Weight: 849.07Molecular Weight (Monoisotopic): 848.4711AlogP: 5.63#Rotatable Bonds: 12
    Polar Surface Area: 201.80Molecular Species: NEUTRALHBA: 12HBD: 4
    #RO5 Violations: 3HBA (Lipinski): 12HBD (Lipinski): 4#RO5 Violations (Lipinski): 3
    CX Acidic pKa: 12.31CX Basic pKa: CX LogP: 4.81CX LogD: 4.81
    Aromatic Rings: 0Heavy Atoms: 61QED Weighted: 0.14Np Likeness Score: 0.97

    References

    1. Baert B, Deconinck E, Van Gele M, Slodicka M, Stoppie P, Bodé S, Slegers G, Vander Heyden Y, Lambert J, Beetens J, De Spiegeleer B..  (2007)  Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds.,  15  (22): [PMID:17827020] [10.1016/j.bmc.2007.07.050]

    Source